Kathmere Capital Management, LLC Astrazeneca PLC Transaction History

Kathmere Capital Management, LLC

$1.02 Billion
Q3 2024

A detailed history of Kathmere Capital Management, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Kathmere Capital Management, LLC holds 6,220 shares of AZN stock, worth $412,137. This represents 0.05% of its overall portfolio holdings.

Number of Shares

6,220

Previous 5,501 13.07%

Holding current value

$412,137

Previous $429,000 12.82%

% of portfolio

0.05%

Previous 0.05%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$76.67 - $87.62 $55,125 - $62,998	719 Added 13.07%	6,220 $484,000
Q2 2024 Jul 17, 2024	BUY	$66.81 - $80.83 $107,630 - $130,217	1,611 Added 41.41%	5,501 $429,000
Q2 2024 Jul 01, 2024	SELL	$66.81 - $80.83 $11,691 - $14,145	-175 Reduced 4.31%	3,890 $303,000
Q1 2024 Apr 16, 2024	BUY	$61.03 - $69.57 $10,680 - $12,174	175 Added 4.5%	4,065 $275,000
Q4 2023 Apr 16, 2024	SELL	$61.89 - $69.28 $77,671 - $86,946	-1,255 Reduced 24.39%	3,890 $261,000
Q3 2023 Oct 11, 2023	BUY	$64.85 - $71.7 $18,936 - $20,936	292 Added 6.02%	5,145 $348,000
Q2 2023 Jul 11, 2023	BUY	$69.91 - $75.81 $25,027 - $27,139	358 Added 7.96%	4,853 $347,000
Q1 2023 Apr 20, 2023	BUY	$63.15 - $71.6 $4,546 - $5,155	72 Added 1.63%	4,495 $311,000
Q4 2022 Jan 24, 2023	BUY	$54.21 - $70.44 $13,389 - $17,398	247 Added 5.65%	4,617 $0
Q4 2022 Jan 24, 2023	SELL	$54.21 - $70.44 $10,516 - $13,665	-194 Reduced 4.2%	4,423 $0
Q3 2022 Oct 11, 2022	SELL	$53.02 - $135.75 $22,533 - $57,693	-425 Reduced 8.86%	4,370 $240,000
Q2 2022 Aug 09, 2022	SELL	$59.26 - $71.14 $33,481 - $40,194	-565 Reduced 10.54%	4,795 $317,000
Q1 2022 Apr 28, 2022	BUY	$55.72 - $67.12 $298,659 - $359,763	5,360 New	5,360 $356,000
Q4 2021 Jan 27, 2022	SELL	$54.02 - $63.83 $217,592 - $257,107	-4,028 Closed	0 $0
Q3 2021 Oct 14, 2021	BUY	$55.56 - $60.79 $223,795 - $244,862	4,028 New	4,028 $242,000
Q1 2021 May 07, 2021	SELL	$47.16 - $54.44 $75,974 - $87,702	-1,611 Closed	0 $0
Q3 2020 Nov 20, 2020	BUY	$53.07 - $61.1 $85,495 - $98,432	1,611 New	1,611 $88,000

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $205B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kathmere Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kathmere Capital Management, LLC with notifications on news.

Account

Kathmere Capital Management, LLC Astrazeneca PLC Transaction History